<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36295660</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Headache in Post-COVID-19 Patients: Its Characteristics and Relationship with the Quality of Life.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1500</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina58101500</ELocationID><Abstract><AbstractText>Little is known on the characteristics of headaches associated with coronavirus disease 2019 (COVID-19) in Indonesia. The objective of this study was to describe the characteristics of headache in post-COVID-19 patients, and its impact on the patients' quality of life (QoL), as well as to determine the associated determinants of the poor QoL. A cross-sectional study was conducted in Banda Aceh, Indonesia. The demographic characteristics, clinical symptoms of COVID-19, characteristics of headache, and the QoL were collected and assessed. Headache was diagnosed and characterized using the International Classification of Headache Disorders, version 3 (ICHD-3). QoL was assessed using a Short Form 36 Health Survey (SF-36) tool. A logistic regression model was used to investigate the associated determinants of poor QoL in post-COVID-19 patients. A total of 215 post-COVID-19 patients were included in the final analysis, and 21.4% (46/215) of them had a poor QoL due to headache following COVID-19. Those who were unemployed and who contracted COVID-19 less than three months prior to the study had higher odds of having poor QoL compared to those who were employed and who contracted COVID-19 more than three months prior to the study. Low QoL was also related to headache that occurred less than one month after recovering from COVID-19 (compared to that which occurred longer than one month after); had a high frequency; had a combination sensation of pulsating, pressing, fiery, and stabbing pain; had a high severity score; and had additional symptoms accompanying the headache. In conclusion, headache related to COVID-19 is associated with low QoL among post-COVID-19 patients. A guideline on prevention measures of headache on COVID-19 patients, therefore, needs to be established to avoid long-term consequences.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mutiawati</LastName><ForeName>Endang</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Dr. Zainoel Abidin Hospital, Banda Aceh 23126, Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusuma</LastName><ForeName>Hendrix Indra</ForeName><Initials>HI</Initials><Identifier Source="ORCID">0000-0003-3555-0136</Identifier><AffiliationInfo><Affiliation>Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Tarbiyah and Teacher Training, Universitas Islam Negeri Ar-Raniry, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahriani</LastName><ForeName>Marhami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harapan</LastName><ForeName>Harapan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7630-8413</Identifier><AffiliationInfo><Affiliation>Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syahrul</LastName><ForeName>Syahrul</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Dr. Zainoel Abidin Hospital, Banda Aceh 23126, Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musadir</LastName><ForeName>Nasrul</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Dr. Zainoel Abidin Hospital, Banda Aceh 23126, Aceh, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 sequelae</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 headache</Keyword><Keyword MajorTopicYN="N">prolonged COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36295660</ArticleId><ArticleId IdType="pmc">PMC9609032</ArticleId><ArticleId IdType="doi">10.3390/medicina58101500</ArticleId><ArticleId IdType="pii">medicina58101500</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S.M., Lau E.H.Y., Wong J.Y., et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J Med. 2020;382:1199&#x2013;1207. doi: 10.1056/NEJMoa2001316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  WHO COVID-19 Dashboard.  [(accessed on 9 June 2022)].  Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>WHO . WHO Director-General&#x2019;s Opening Remarks at the Media Briefing on COVID-19. WHO; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>Maital S., Barzani E. The global economic impact of COVID-19: A summary of research. Samuel Neaman Inst. Natl. Policy Res. 2020;2020:1&#x2013;12.</Citation></Reference><Reference><Citation>Miller I.F., Becker A.D., Grenfell B.T., Metcalf C.J.E. Disease and healthcare burden of COVID-19 in the United States. Nat. Med. 2020;26:1212&#x2013;1217. doi: 10.1038/s41591-020-0952-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0952-y</ArticleId><ArticleId IdType="pubmed">32546823</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K., Worsnop C.Z., Gr&#xe9;pin K.A., Kamradt-Scott A. Global coordination on cross-border travel and trade measures crucial to COVID-19 response. Lancet. 2020;395:1593&#x2013;1595. doi: 10.1016/S0140-6736(20)31032-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31032-1</ArticleId><ArticleId IdType="pmc">PMC7255339</ArticleId><ArticleId IdType="pubmed">32416788</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan W., Kazmi S.K., Tahir M.J., Ullah I., Royan H.A., Fahriani M., Nainu F., Rosa S.G.V. Global acceptance and hesitancy of COVID-19 vaccination: A narrative review. Narra. J. 2021;1:e57. doi: 10.52225/narra.v1i3.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narra.v1i3.57</ArticleId><ArticleId IdType="pmc">PMC10914054</ArticleId><ArticleId IdType="pubmed">38450215</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosiello D., Anwar S., Yufika A., Adam R., Ismaeil M., Ismail A., Dahman N., Hafsi M., Ferjani M., Sami F., et al. Acceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in ten countries in Asia, Africa, and South America. Narra. J. 2021;1:e55. doi: 10.52225/narra.v1i3.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narra.v1i3.55</ArticleId><ArticleId IdType="pmc">PMC10914086</ArticleId><ArticleId IdType="pubmed">38450212</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan H., Itoh N., Yufika A., Winardi W., Keam S., Te H., Megawati D., Hayati Z., Wagner A.L., Mudatsir M. Coronavirus disease 2019 (COVID-19): A literature review. J. Infect. Public Health. 2020;13:667&#x2013;673. doi: 10.1016/j.jiph.2020.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.03.019</ArticleId><ArticleId IdType="pmc">PMC7142680</ArticleId><ArticleId IdType="pubmed">32340833</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., Barnaby D.P., Becker L.B., Chelico J.D., Cohen S.L., et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052&#x2013;2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72,314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimohamadi Y., Sepandi M., Rashti R., Nezhad H.S., Afrashteh S. COVID-19: Clinical features, case fatality, and the effect of symptoms on mortality in hospitalized cases in Iran. J. Taibah Univ. Med. Sci. 2022;17:725&#x2013;731. doi: 10.1016/j.jtumed.2022.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtumed.2022.04.010</ArticleId><ArticleId IdType="pmc">PMC9088159</ArticleId><ArticleId IdType="pubmed">35571593</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimohamadi Y., Sepandi M., Taghdir M., Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: A systematic review and meta-analysis. J. Prev. Med. Hyg. 2020;61:E304&#x2013;E312. doi: 10.15167/2421-4248/jpmh2020.61.3.1530.</Citation><ArticleIdList><ArticleId IdType="doi">10.15167/2421-4248/jpmh2020.61.3.1530</ArticleId><ArticleId IdType="pmc">PMC7595075</ArticleId><ArticleId IdType="pubmed">33150219</ArticleId></ArticleIdList></Reference><Reference><Citation>Seang S., Itani O., Monsel G., Abdi B., Marcelin A.G., Valantin M.A., Palich R., Faycal A., Pourcher V., Katlama C., et al. Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up. Infect. Dis. Now. 2022;52:165&#x2013;169. doi: 10.1016/j.idnow.2022.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2022.02.005</ArticleId><ArticleId IdType="pmc">PMC8832844</ArticleId><ArticleId IdType="pubmed">35158095</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonoda S., Kuramochi J., Matsuyama Y., Miyazaki Y., Fujiwara T. Validity of Clinical Symptoms Score to Discriminate Patients with COVID-19 from Common Cold Out-Patients in General Practitioner Clinics in Japan. J. Clin. Med. 2021;10:854. doi: 10.3390/jcm10040854.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040854</ArticleId><ArticleId IdType="pmc">PMC7922190</ArticleId><ArticleId IdType="pubmed">33669685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.S., Chin B.S., Kang C.K., Kim N.J., Kang Y.M., Choi J.P., Oh D.H., Kim J.H., Koh B., Kim S.E., et al. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. J. Korean Med. Sci. 2020;35:e142. doi: 10.3346/jkms.2020.35.e142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e142</ArticleId><ArticleId IdType="pmc">PMC7131901</ArticleId><ArticleId IdType="pubmed">32242348</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W.H., Guan W.J., Li C.C., Li Y.M., Liang H.R., Zhao Y., Liu X.Q., Sang L., Chen R.C., Tang C.L., et al. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): A nationwide analysis of China. Eur. Respir. J. 2020;55:200562. doi: 10.1183/13993003.00562-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00562-2020</ArticleId><ArticleId IdType="pmc">PMC7144336</ArticleId><ArticleId IdType="pubmed">32269086</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahriani M., Ilmawan M., Fajar J.K., Maliga H.A., Frediansyah A., Masyeni S., Yusuf H., Nainu F., Rosiello F., Sirinam S. Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis-a systematic review and meta-Analysis. Narra. J. 2021;1:e36. doi: 10.52225/narraj.v1i2.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narraj.v1i2.36</ArticleId><ArticleId IdType="pmc">PMC10914031</ArticleId><ArticleId IdType="pubmed">38449463</ArticleId></ArticleIdList></Reference><Reference><Citation>An Y., Yang Y., Wang A., Li Y., Zhang Q., Cheung T., Ungvari G.S., Qin M.-Z., An F.-R., Xiang Y.-T. Prevalence of depression and its impact on quality of life among frontline nurses in emergency departments during the COVID-19 outbreak. J. Affect. Disord. 2020;276:312&#x2013;315. doi: 10.1016/j.jad.2020.06.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.06.047</ArticleId><ArticleId IdType="pmc">PMC7361044</ArticleId><ArticleId IdType="pubmed">32871661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ci&#x105;&#x17c;y&#x144;ska M., Pabianek M., Szczepaniak K., U&#x142;a&#x144;ska M., Skibi&#x144;ska M., Owczarek W., Narbutt J., Lesiak A. Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic. Psychooncology. 2020;29:1377&#x2013;1379. doi: 10.1002/pon.5434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.5434</ArticleId><ArticleId IdType="pmc">PMC7323427</ArticleId><ArticleId IdType="pubmed">32779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens-Sieberer U., Kaman A., Otto C., Adedeji A., Devine J., Erhart M., Napp A.K., Becker M., Blanck-Stellmacher U., L&#xf6;ffler C., et al. Mental Health and Quality of Life in Children and Adolescents During the COVID-19 Pandemic-Results of the Copsy Study. Dtsch. Arztebl. Int. 2020;117:828&#x2013;829. doi: 10.3238/arztebl.2020.0828.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2020.0828</ArticleId><ArticleId IdType="pmc">PMC8005842</ArticleId><ArticleId IdType="pubmed">33568260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y.F., Li W., Deng H.B., Wang L., Wang Y., Wang P.H., Bo H.X., Cao J., Wang Y., Zhu L.Y., et al. Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19. J. Affect. Disord. 2020;275:145&#x2013;148. doi: 10.1016/j.jad.2020.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.06.033</ArticleId><ArticleId IdType="pmc">PMC7329672</ArticleId><ArticleId IdType="pubmed">32658818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidzan-Bluma I., Bidzan M., Jurek P., Bidzan L., Knietzsch J., Stueck M., Bidzan M. A Polish and German Population Study of Quality of Life, Well-Being, and Life Satisfaction in Older Adults During the COVID-19 Pandemic. Front. Psychiatry. 2020;11:585813. doi: 10.3389/fpsyt.2020.585813.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.585813</ArticleId><ArticleId IdType="pmc">PMC7705096</ArticleId><ArticleId IdType="pubmed">33281646</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab-Zozani M., Hashemi F., Safari H., Yousefi M., Ameri H. Health-Related Quality of Life and its Associated Factors in COVID-19 Patients. Osong Public Health Res. Perspect. 2020;11:296&#x2013;302. doi: 10.24171/j.phrp.2020.11.5.05.</Citation><ArticleIdList><ArticleId IdType="doi">10.24171/j.phrp.2020.11.5.05</ArticleId><ArticleId IdType="pmc">PMC7577388</ArticleId><ArticleId IdType="pubmed">33117634</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajar J.K., Ilmawan M., Mamada S., Mutiawati E., Husnah M., Yusuf H., Nainu F., Sirinam S., Keam S., Ophinni Y. Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis. Narra. J. 2021;1:e48. doi: 10.52225/narra.v1i3.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narra.v1i3.48</ArticleId><ArticleId IdType="pmc">PMC10914045</ArticleId><ArticleId IdType="pubmed">38450213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf F., Fahriani M., Mamada S.S., Frediansyah A., Abubakar A., Maghfirah D., Fajar J.K., Maliga H.A., Ilmawan M., Emran T.B., et al. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-Analysis. F1000Res. 2021;10:301. doi: 10.12688/f1000research.52216.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52216.1</ArticleId><ArticleId IdType="pmc">PMC8171196</ArticleId><ArticleId IdType="pubmed">34131481</ArticleId></ArticleIdList></Reference><Reference><Citation>Khraisat B., Toubasi A., AlZoubi L., Al-Sayegh T., Mansour A. Meta-Analysis of prevalence: The psychological sequelae among COVID-19 survivors. Int. J. Psychiatry Clin. Pract. 2021;26:234&#x2013;243. doi: 10.1080/13651501.2021.1993924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651501.2021.1993924</ArticleId><ArticleId IdType="pubmed">34709105</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R., Balanz&#xe1;-Mart&#xed;nez V., Luperdi S.C., Estrada I., Latorre A., Gonz&#xe1;lez-Jim&#xe9;nez P., Feced L., Bouzas L., Y&#xe9;pez K., Ferrando A., et al. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J. Intern. Med. 2021;290:621&#x2013;631. doi: 10.1111/joim.13262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13262</ArticleId><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandmann F.G., Tessier E., Lacy J., Kall M., Van Leeuwen E., Charlett A., Eggo R.M., Dabrera G., Edmunds W.J., Ramsay M., et al. Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls. Clin. Infect. Dis. 2022;75:e962&#x2013;e973. doi: 10.1093/cid/ciac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac151</ArticleId><ArticleId IdType="pmc">PMC8903473</ArticleId><ArticleId IdType="pubmed">35245941</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman M.M., Abd-Elrahman N.M., Bakheet T.M. Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study. J. Med. Virol. 2021;93:5942&#x2013;5946. doi: 10.1002/jmv.27156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27156</ArticleId><ArticleId IdType="pmc">PMC8426945</ArticleId><ArticleId IdType="pubmed">34171139</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Garc&#xed;a-Azor&#xed;n D., Arendt-Nielsen L., Plaza-Manzano G. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur. J. Neurol. 2021;28:3820&#x2013;3825. doi: 10.1111/ene.15040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Ballv&#xe9; A., Llaurad&#xf3; A., Gallardo V.J., Ariton D.M., Lallana S., L&#xf3;pez Maza S., Oliv&#xe9; Gadea M., Quibus L., Restrepo J.L., et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40:1410&#x2013;1421. doi: 10.1177/0333102420965157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965157</ArticleId><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio Rocha-Filho P.A., Magalh&#xe3;es J.E. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia. Cephalalgia. 2020;40:1443&#x2013;1451. doi: 10.1177/0333102420966770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420966770</ArticleId><ArticleId IdType="pmc">PMC7645592</ArticleId><ArticleId IdType="pubmed">33146035</ArticleId></ArticleIdList></Reference><Reference><Citation>Barulin A., Kurushina O., Drushlyakova A. Headache in patients with COVID-19. J. Neurol. Sci. 2021;429:119291. doi: 10.1016/j.jns.2021.119291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.119291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio Rocha-Filho P.A., Albuquerque P.M., Carvalho L., Dandara Pereira Gama M., Magalhaes J.E. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: A cross-Sectional study. J. Headache Pain. 2022;23:2. doi: 10.1186/s10194-021-01367-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01367-8</ArticleId><ArticleId IdType="pmc">PMC8721484</ArticleId><ArticleId IdType="pubmed">34979899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiawati E., Syahrul S., Fahriani M., Fajar J.K., Mamada S.S., Maliga H.A., Samsu N., Ilmawan M., Purnamasari Y., Asmiragani A.A., et al. Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-Analysis. F1000Res. 2020;9:1316. doi: 10.12688/f1000research.27334.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27334.1</ArticleId><ArticleId IdType="pmc">PMC8063523</ArticleId><ArticleId IdType="pubmed">33953911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.M., An J. Cytokines, inflammation, and pain. Int. Anesthesiol. Clin. 2007;45:27&#x2013;37. doi: 10.1097/AIA.0b013e318034194e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AIA.0b013e318034194e</ArticleId><ArticleId IdType="pmc">PMC2785020</ArticleId><ArticleId IdType="pubmed">17426506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H., G&#xfc;l A., Baykan B. COVID-19 is a real headache! Headache J. Head Face Pain. 2020;60:1415&#x2013;1421. doi: 10.1111/head.13856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13856</ArticleId><ArticleId IdType="pmc">PMC7272895</ArticleId><ArticleId IdType="pubmed">32412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Uygun O., Ertas M., Ekizoglu E., Bolay H., Ozge A., Kocasoy Orhan E., Cagatay A.A., Baykan B. Headache characteristics in COVID-19 pandemic-a survey study. J. Headache Pain. 2020;21:121. doi: 10.1186/s10194-020-01188-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-020-01188-1</ArticleId><ArticleId IdType="pmc">PMC7552597</ArticleId><ArticleId IdType="pubmed">33050880</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez J.T., Garc&#xed;a-Azor&#xed;n D., Planchuelo-G&#xf3;mez &#xc1;., Garc&#xed;a-Iglesias C., Due&#xf1;as-Guti&#xe9;rrez C., Guerrero &#xc1;.L. Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020;40:1432&#x2013;1442. doi: 10.1177/0333102420965146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965146</ArticleId><ArticleId IdType="pmc">PMC7645601</ArticleId><ArticleId IdType="pubmed">33146037</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues R., Kuster G., de Castro F.O., Souza V., Levi J., Pannuti C. Headache Features in Patients with Dengue Virus Infection. Cephalalgia. 2006;26:879&#x2013;882. doi: 10.1111/j.1468-2982.2006.01100.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-2982.2006.01100.x</ArticleId><ArticleId IdType="pubmed">16776706</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold M. Headache Classification Committee of the International Headache Society (IHS) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1&#x2013;211. doi: 10.1177/0333102417738202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102417738202</ArticleId><ArticleId IdType="pubmed">29368949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., Cortes M., Kontorovich A., McCarthy D., Rizk D., Rozanski G., Breyman E., Nasr L., et al. Post-Acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation. Am. J. Phys. Med. Rehabil. 2022;101:48&#x2013;52. doi: 10.1097/PHM.0000000000001910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes A.W., Go&#xeb;rtz Y.M.J., Van Herck M., Machado F.V.C., Meys R., Delbressine J.M., Houben-Wilke S., Gaffron S., Maier D., Burtin C., et al. Recovery from COVID-19: A sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. 2021;7:00141&#x2013;02021. doi: 10.1183/23120541.00141-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00141-2021</ArticleId><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="pubmed">34041295</ArticleId></ArticleIdList></Reference><Reference><Citation>Planchuelo-G&#xf3;mez &#xc1;., Trigo J., de Luis-Garc&#xed;a R., Guerrero &#xc1;.L., Porta-Etessam J., Garc&#xed;a-Azor&#xed;n D. Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis. Front. Neurol. 2020;11:583870. doi: 10.3389/fneur.2020.583870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.583870</ArticleId><ArticleId IdType="pmc">PMC7773780</ArticleId><ArticleId IdType="pubmed">33391152</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-Acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-Analysis. J. Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Thawani S., Kenney R., Hasanaj L., Frontera J., Galetta S., Balcer L. Headache Frequency and Quality of Life in Patients with Post-Acute Sequelae of COVID-19 (P9-2.003) Neurology. 2022;98((Suppl. S18)):3870.</Citation></Reference><Reference><Citation>Krymchantowski A.V., Silva-N&#xe9;to R.P., Jevoux C., Krymchantowski A.G. Indomethacin for refractory COVID or post-COVID headache: A retrospective study. Acta Neurol. Belg. 2022;122:465&#x2013;469. doi: 10.1007/s13760-021-01790-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01790-3</ArticleId><ArticleId IdType="pmc">PMC8453033</ArticleId><ArticleId IdType="pubmed">34546559</ArticleId></ArticleIdList></Reference><Reference><Citation>Baykan B., &#xd6;zge A., Erta&#x15f; M., Atalar A., Bolay H. Urgent Need for ICHD Criteria for COVID-19-Related Headache: Scrutinized Classification Opens the Way for Research. Noro Psikiyatr. Ars. 2021;58:79&#x2013;80. doi: 10.29399/npa.27736.</Citation><ArticleIdList><ArticleId IdType="doi">10.29399/npa.27736</ArticleId><ArticleId IdType="pmc">PMC7980718</ArticleId><ArticleId IdType="pubmed">33795959</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . WHOQOL User Manual. WHO; Geneva, Switzerland: 2012. WHO/MNH/MHP/98.4.Rev.1.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>